Iothalamic acid
Angio-conray, Conray, Cysto-conray, Vascoray (iothalamic acid) is a small molecule pharmaceutical. Iothalamic acid was first approved as Conray on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Conray, Cysto-conray (discontinued: Angio-conray, Conray)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Iothalamate meglumine
Iothalamate meglumine
+
Iothalamate sodium
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VASCORAY | Mallinckrodt | N-016783 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
cysto-conray ii | New Drug Application | 2020-12-31 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/trials-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
Kidney transplantation | D016030 | — | — | — | — | 1 | 1 | ||
Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | IOTHALAMIC ACID |
INN | iotalamic acid |
Description | Iotalamic acid is an organic molecular entity. |
Classification | Small molecule |
Drug class | iodine-containing contrast media |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I |
Identifiers
PDB | — |
CAS-ID | 2276-90-6 |
RxCUI | 1546451 |
ChEMBL ID | CHEMBL1201300 |
ChEBI ID | — |
PubChem CID | 3737 |
DrugBank | DB09133 |
UNII ID | 16CHD79MIX (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-terms-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 145 documents
View more details
Safety
Black-box Warning
Black-box warning for: Cysto-conray ii
Adverse Events
Top Adverse Reactions
![](https://www.pharmakb.com/hubfs/raw_assets/public/ccd-theme/images/generated-html-images/top-adverse-reactions-plot.png)
Mock data
Subscribe for the real data
Subscribe for the real data
314 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more